IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Aveni Foundation
University of California, Irvine
Dana-Farber Cancer Institute
Kaiser Permanente
University of Florida
Essen Biotech
Institut Curie
University of Nebraska
M.D. Anderson Cancer Center
University Health Network, Toronto
University of Southern California
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Hadassah Medical Organization
City of Hope Medical Center
Institut Bergonié
Washington University School of Medicine
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
University of California, Irvine
Institut Bergonié
University of California, Irvine
Roswell Park Cancer Institute
Esperas Pharma Inc.
Region Skane
University of South Florida
Stanford University
Northwestern University
Mayo Clinic
Stanford University
Second Affiliated Hospital of Guangzhou Medical University
Memorial Sloan Kettering Cancer Center
UNICANCER
OHSU Knight Cancer Institute
Emory University
City of Hope Medical Center
Scripps Health
Ludwig Institute for Cancer Research
Cancer Research UK, Glasgow
Istituto Clinico Humanitas
Roswell Park Cancer Institute
Australia New Zealand Gynaecological Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cambridge University Hospitals NHS Foundation Trust
CureOne
Mie University
Mayo Clinic
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota